Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis. (Q42598993)
Jump to navigation
Jump to search
scientific article published on October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis. |
scientific article published on October 2008 |
Statements
Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis (English)
E Messa
D Cilloni